Why It Matters

The Cancer Panel provides a multi-organ tumor marker assessment designed to support detection, monitoring, and risk evaluation across several major cancer types. By combining markers associated with ovarian, breast, gastrointestinal, liver, and prostate cancers, this panel offers a broader screening approach that may help identify abnormal activity earlier and assist in ongoing disease surveillance.

Who Should Get It

Recommended for individuals with family history of cancer, prior cancer diagnosis, elevated cancer risk factors, unexplained symptoms, or patients undergoing cancer monitoring after treatment or remission. It is also valuable as part of comprehensive wellness screening for adults over 50.

How This Panel Is Used

Physicians use the Cancer Panel to monitor tumor marker trends, support cancer surveillance, evaluate treatment response, and assist in risk assessment for multiple organ systems. It is commonly ordered during oncology follow-up, preventive evaluations, and executive wellness screening.

What’s Included

This panel includes tumor markers associated with ovarian, breast, gastrointestinal, liver, and prostate cancers, providing a broader assessment of cancer-related biomarker activity across multiple organ systems.

Name

Text

Together, these biomarkers provide a comprehensive multi-organ tumor marker assessment, supporting cancer monitoring, risk evaluation, and more informed clinical decision-making.